Drug profile · INN
collagenase clostridium histolyticum-aaes
QWO
collagenase clostridium histolyticum-aaes (QWO) is a collagen hydrolytic enzyme. Route of administration: subcutaneous. Current US regulatory status: approved.
Drug details — collagenase clostridium histolyticum-aaes
- US status
- approved
- Class
- —
- Route
- SUBCUTANEOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
collagenase clostridium histolyticum-aaes (QWO) is a collagen hydrolytic enzyme. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
Mechanism of action
Collagen hydrolytic enzyme
Primary target: Collagen
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is collagenase clostridium histolyticum-aaes?
collagenase clostridium histolyticum-aaes (QWO) is a collagen hydrolytic enzyme. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for collagenase clostridium histolyticum-aaes?
QWO is a marketed brand name for collagenase clostridium histolyticum-aaes. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of collagenase clostridium histolyticum-aaes?
collagenase clostridium histolyticum-aaes has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.